170373 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates; Assays involving proteins of known structure or function as defined in the subgroups; Details Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
SYSTEMS AND METHODS FOR DIAGNOSING HEPATOCELLULAR CARCINOMA BASED ON THE DETECTION AND INTERPRETATION OF A PANEL OF MICRORNAS IN A SUBJECT
#2Disposable Indicator
#3IMPROVED ASSAY COMPOSITIONS AND METHODS
#4EX VIVO PROTEASE ACTIVITY DETECTION FOR HEPATOCELLULAR CARCINOMA
#5HIGH AFFINITY ANTIBODIES SPECIFICALLY BINDING TO a-1,6-CORE-FUCOSYLATED ALPHA-FETOPROTEIN
#6ISOLATION OF FETAL NEURONAL EXTRACELLULAR VESICLES
#7BIOMARKER PAIRS AND TRIPLETS FOR PREDICTING PRETERM BIRTH
#8BIOSENSOR IMPLEMENTING FP-WA COUPLING MODE, PREPARATION METHOD THEREFOR, AND USE THEREOF
#9WASTEWATER-BASED EPIDEMIOLOGY METHODS FOR ASSESSING POPULATION HEALTH
#10METHOD FOR TREATING HEPATOCELLULAR CARCINOMA
#11Biomarker for preeclampsia
#12CIRCULATING MICRORNA AS A MARKER FOR HEPATOCELLULAR CARCINOMA
#13Lectin-binding substance measurement method, lectin-binding substance measurement kit, and capture carrier for use in these
#14Lectin-binding substance measurement method, lectin-binding substance measurement kit, and blocked labeled lectin for use in these
#15PREECLAMPSIA BIOMARKERS AND RELATED SYSTEMS AND METHODS
#16METHODS FOR PREDICTING TIME-TO-DELIVERY IN PREGNANT WOMEN
#17BIOMARKER CEREBLON FOR DIAGNOSING HEPATOCELLULAR CARCINOMA, AND NOVEL MONOCLONAL ANTIBODY SPECIFIC THERETO
#18Preeclampsia biomarkers and related systems and methods
#19CIRCULATORY BIOMARKERS FOR PLACENTAL OR FETAL HEALTH
#20NOVEL PREGNANCY DIAGNOSIS DEVICE INCLUDING BETA-CORE FRAGMENT HCG AS MARKER
#21Noninvasive molecular controls
#22PREECLAMPSIA BIOMARKERS AND RELATED SYSTEMS AND METHODS
#23Circulating microRNA as a marker for hepatocellular carcinoma
#24Quantitative profiling of progesterone metabolites for the prediction of spontaneous preterm delivery
#25Diagnostic method of liver cancer using α-fetoprotein derived glycopeptides by mass spectrometry
#26A NEW BIOMARKER FOR PREECLAMPSIA
#27System and method for remote colorimetry and ratiometric comparison and quantification in analysis of medical test results
#28Detection of amniotic fluid in vaginal secretions of pregnant women due to premature rupture of fetal membranes
#29METHOD OF TREATMENT AND PROGNOSIS
#30Quantitative profiling of progesterone metabolites for the prediction of spontaneous preterm delivery
#31HIGH-THROUGHPUT EARLY DETECTION AND POINT-OF-CARE EARLY DETECTION OF PREGNANT WOMEN SUSCEPTIBLE TO DEVELOPING PREECLAMPSIA
#32METHODS AND COMPOSITIONS FOR DIAGNOSIS OF ECTOPIC PREGNANCY
#33Determining candidate for induction of labor
#34Screening asymptomatic pregnant woman for preterm birth
#35Circulating microRNA as a marker for hepatocellular carcinoma
#36Methods for predicting time-to-delivery in pregnant women
#37Method for detecting AFP
#38Monoclonal antibody reacting with glycopeptide, and use thereof
#39METHODS FOR DETECTING GESTATIONAL DIABETES MELLITUS
#40Methods and compositions for diagnosis of ectopic pregnancy
#41EARLY PLACENTA INSULIN-LIKE PEPTIDE (PRO-EPIL)
#42Devices and methods for detecting amniotic fluid in vaginal secretions
#43Methods for Determining The Risk of Prenatal Complications
#44Methods for predicting time-to-delivery in pregnant women
#45PIF-TRANSFECTED CELLS AND METHODS OF USE
#46Chemiluminescent Protein Chip, Method and Kit for Detecting Seroglycoid Fucosylation Index
#47Autoantibody Signature for the Early Detection of Ovarian Cancer
#48HIGH-THROUGHPUT EARLY DETECTION AND POINT-OF-CARE EARLY DETECTION OF PREGNANT WOMEN SUSCEPTIBLE TO DEVELOPING PREECLAMPSIA
#49Methods for detecting oncofetal fibronectin
#50Maternal biomarkers for gestational diabetes
#51DIAGNOSTIC AND PROGNOSTIC USE OF PROMBP-COMPLEXES
#52Detection of amniotic fluid in vaginal secretions of pregnant women due to premature rupture of fetal membranes
#53Methods for determining the risk of prenatal complications
#54Devices and methods for detecting amniotic fluid in vaginal secretions
#55METHODS AND COMPOSITIONS FOR DIAGNOSTIC USE IN CANCER PATIENTS
#56Inhibition of the interaction between 5T4 oncofoetal glycoproteins and CXC chemokine receptors as a method of identifying chemotaxis inhibitors
#57METHOD FOR DIAGNOSING ACUTE CORONARY SYNDROME
#58Methods and compositions for diagnosis of ectopic pregnancy
#59Methods for detecting oncofetal fibronectin
#60Devices and methods for detecting amniotic fluid in vaginal secretions
#61Circulating microRNA as a marker for hepatocellular carcinoma
#62Methods and apparatus for screening for chromosomal abnormalities
#63CIRCULATING MICRORNA AS A MARKER FOR HEPATOCELLULAR CARCINOMA
#64Use of the IRAP protein for implementing methods of diagnosis and of prognosis
#65Method for assessing oocyte maturation
#66Compositions and methods for early pregnancy diagnosis
#67METHOD FOR RISK REDUCTION IN GLYCEMIC CONTROL
#68METHOD FOR DIAGNOSING ACUTE CORONARY SYNDROME
#69Compositions and methods for early pregnancy diagnosis
#70Devices and methods for detecting amniotic fluid in vaginal secretions
#71Methods for determining the risk of prenatal complications
#72METHODS AND COMPOSITIONS FOR DIAGNOSTIC USE IN CANCER PATIENTS
#73DIAGNOSTIC TEST FOR HEPATOCELLULAR CARCINOMA
#74Method of diagnosis of pregnancy-related complications
#75Method for Determining the Effectiveness of a Treatment for Preeclampsia
#76CD44E tumor specific antibody
#77Detection and treatment of cancer
#78Screen for pre-eclampsia
#79Compositions and methods for early pregnancy diagnosis
#80Methods and apparatus for screening for chromosomal abmormalities
#81METHODS FOR DIAGNOSING HEPATOCELLULAR CARCINOMA
#82Method for diagnosing acute coronary syndrome
#83Multimarker panel for diabetes type 1 and 2
#84Devices and methods for detecting amniotic fluid in vaginal secretions
#85Non-invasive assessment of intra-amniotic environment
#86Biological marker for inflammation
#87Method of diagnosis of pregnancy-related complications
#88Detection of oncofetal fibronectin for selection of concepti
#89Oncofetal fibronectin as a marker for pregnancy-related indications
#90Oncofetal fibronectin as a marker for health and disease
#91Methods for detecting oncofetal fibronectin
#92Samples for detection of oncofetal fibronectin and uses thereof
#93Multimarker panel for diabetes type 1 and 2
#94Compositions and methods for early pregnancy diagnosis